Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Metabolomic profiles discriminating anxiety from depression
Hilde de Kluiver, Rick Jansen, Yuri Milaneschi, et al.
Acta Psychiatrica Scandinavica (2021) Vol. 144, Iss. 2, pp. 178-193
Open Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

The association between adolescent depression and dyslipidemia
Anisa F. Khalfan, Susan C. Campisi, Ronda F. Lo, et al.
Journal of Affective Disorders (2023) Vol. 338, pp. 239-245
Closed Access | Times Cited: 21
Metabolomics signatures of depression: the role of symptom profiles
Hilde de Kluiver, Rick Jansen, Brenda W.J.H. Penninx, et al.
Translational Psychiatry (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 16
Systematic identification of the role of gut microbiota in mental disorders: a TwinsUK cohort study
Julie Delanote, Alejandro Correa Rojo, Philippa M. Wells, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 6
Metabolomics of Major Depressive Disorder: A Systematic Review of Clinical Studies
Livia N F. Guerreiro Costa, Beatriz A Carneiro, Gustavo S. Alves, et al.
Cureus (2022)
Open Access | Times Cited: 23
Prevalence and correlates of severe anxiety in patients with first hospitalization for major depressive disorder combined with dyslipidemia: a large sample cross-sectional study
Huimin Yin, Qi Zhang, Yi Li, et al.
Frontiers in Psychiatry (2024) Vol. 14
Open Access | Times Cited: 5
The identification of plasma and cerebrospinal fluid metabolites causally associated with mental disorders from a genetic perspective
Yanhong Song, Xiaodong Wu, Ziyi Wu, et al.
Journal of Affective Disorders (2025) Vol. 373, pp. 438-448
Closed Access
Predicting incident cardio-metabolic disease among persons with and without depressive and anxiety disorders: a machine learning approach
Arja O. Rydin, George Aalbers, Wessel A. van Eeden, et al.
Social Psychiatry and Psychiatric Epidemiology (2025)
Open Access
Integration of metabolomic and brain-imaging data highlights pleiotropy among posttraumatic stress disorder, glycoprotein acetyls, and pallidum structure
Solveig Løkhammer, Markos Tesfaye, Brenda Cabrera‐Mendoza, et al.
Biological Psychiatry Global Open Science (2025), pp. 100482-100482
Open Access
Exploring the role of ketone bodies in the diagnosis and treatment of psychiatric disorders
Naomi Elyse Omori, Mantas Kazimieras Malys, Geoffrey Hubert Woo, et al.
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 9
A network analysis of depressive symptoms and metabolomics
Arja O. Rydin, Yuri Milaneschi, Rick Quax, et al.
Psychological Medicine (2023) Vol. 53, Iss. 15, pp. 7385-7394
Open Access | Times Cited: 9
Specific metabolic syndrome components predict cognition and social functioning in people with type 2 diabetes mellitus and severe mental disorders
Joan Vicent Sánchez‐Ortí, Vicent Balanzá‐Martínez, Patricia Correa‐Ghisays, et al.
Acta Psychiatrica Scandinavica (2022) Vol. 146, Iss. 3, pp. 215-226
Open Access | Times Cited: 15
Normal range CAG repeat size variations in the HTT gene are associated with an adverse lipoprotein profile partially mediated by body mass index
Tariq Faquih, N. Ahmad Aziz, Sarah L. Gardiner, et al.
Human Molecular Genetics (2023) Vol. 32, Iss. 10, pp. 1741-1752
Open Access | Times Cited: 8
Targeting Metabolic Dysfunction for the Treatment of Mood Disorders: Review of the Evidence
Brett D. M. Jones, Salman Farooqui, Stefan Kloiber, et al.
Life (2021) Vol. 11, Iss. 8, pp. 819-819
Open Access | Times Cited: 20
High persistence and low treatment rates of metabolic syndrome in patients with mood and anxiety disorders: A naturalistic follow-up study
J. Brouwer, Klaas J. Wardenaar, Edith J. Liemburg, et al.
Journal of Affective Disorders (2024) Vol. 354, pp. 451-462
Open Access | Times Cited: 2
Probiotics may be useful for drug-induced liver dysfunction in patients with depression – A secondary analysis of a randomized clinical trial
Oliwia Gawlik-Kotelnicka, Jacek Burzyński, Jakub Rogalski, et al.
Clinical Nutrition ESPEN (2024) Vol. 63, pp. 604-614
Open Access | Times Cited: 2
The contribution of polyamine pathway to determinations of diagnosis for treatment-resistant depression: A metabolomic analysis
Zerui You, Chengyu Wang, Xiaofeng Lan, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2023) Vol. 128, pp. 110849-110849
Closed Access | Times Cited: 6
Metabolomics profiling of Type D personality traits
Ruifang Li‐Gao, Mariska Bot, Alexander Kurilshikov, et al.
Journal of Psychosomatic Research (2024) Vol. 188, pp. 111994-111994
Open Access | Times Cited: 1
Discovery and validation of acetyl-L-carnitine in serum for diagnosis of major depressive disorder and remission status through metabolomic approach
Seungyeon Lee, Sora Mun, You‐Rim Lee, et al.
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 5
Mental health and validity of the psycho-neurobiological stress model

American Journal of Psychiatric Research and Reviews (2022), pp. 34-34
Open Access | Times Cited: 4
Serum metabolomic profiling revealed potential diagnostic biomarkers in patients with panic disorder
Dandan Shan, Linlin You, Xuerui Wan, et al.
Journal of Affective Disorders (2022) Vol. 323, pp. 461-471
Closed Access | Times Cited: 4
Childhood adversities and the comorbidity between mood and general medical disorders in adults: Results from the WHO World Mental Health Survey Portugal
J. Oliveira, Vítor Paixão, Graça Cardoso, et al.
Brain Behavior & Immunity - Health (2021) Vol. 17, pp. 100329-100329
Open Access | Times Cited: 4
Intricate mechanism of anxiety disorder, recognizing the potential role of gut microbiota and therapeutic interventions
Sudarshan Singh Lakhawat, Paulina Mech, Akhilesh Kumar, et al.
Metabolic Brain Disease (2024) Vol. 40, Iss. 1
Closed Access
Metabolomics and Self-Reported Depression, Anxiety, and Phobic Symptoms in the VA Normative Aging Study
Nicole Prince, Meryl Stav, Margaret Cote, et al.
Metabolites (2023) Vol. 13, Iss. 7, pp. 851-851
Open Access | Times Cited: 1
Metabolites and depressive symptoms: Network- and longitudinal analyses from the Finnish Depression and Metabolic Syndrome in Adults (FDMSA) Study
Guro Pauck Bernhardsen, Owen Thomas, Pekka Mäntyselkä, et al.
Journal of Affective Disorders (2023) Vol. 347, pp. 199-209
Open Access | Times Cited: 1
NMR Metabolomics for Marker Discovery of Metabolic Syndrome
Sergio Quesada‐Vázquez, Julia Hernández-Baixauli, Èlia Navarro‐Masip, et al.
Biomarkers in disease (2022), pp. 651-678
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top